| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NewAmsterdam Pharma Co N.V. | Chief Financial Officer | Ordinary Shares | 58,382 | $1,973,311 | $33.80 | 21 Jan 2026 | Direct |
| NewAmsterdam Pharma Co N.V. | Chief Financial Officer | Option (Right to Buy) | 662,814 | 21 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | 20 Jan 2026 | 9 | -$2,334,618 | 4 | Chief Financial Officer | 22 Jan 2026, 17:24 |
| NAMS | NewAmsterdam Pharma Co N.V. | 05 Jan 2026 | 3 | -$170,174 | 4 | Chief Financial Officer | 07 Jan 2026, 18:27 |
| NAMS | NewAmsterdam Pharma Co N.V. | 27 Jan 2025 | 8 | +$573,037 | 4 | Chief Financial Officer | 29 Jan 2025, 17:25 |
| NAMS | NewAmsterdam Pharma Co N.V. | 07 Jan 2025 | 1 | $0 | 4 | Chief Financial Officer | 07 Jan 2025, 17:08 |
| NAMS | NewAmsterdam Pharma Co N.V. | 02 Jan 2025 | 1 | $0 | 4 | Chief Financial Officer | 06 Jan 2025, 17:53 |
| NAMS | NewAmsterdam Pharma Co N.V. | 01 Jan 2024 | 1 | $0 | 4 | Chief Financial Officer | 03 Jan 2024, 17:10 |
| NAMS | NewAmsterdam Pharma Co N.V. | 29 Dec 2023 | 0 | $0 | 3 | Chief Financial Officer | 29 Dec 2023, 16:30 |